Hair loss might be the most commercially aggressive corner of men's health. Search for it once and you're in a funnel of supplements, lasers, clinics and subscriptions. Podcasts are one of the few places the topic gets discussed at length without a checkout page attached. Here's what's worth your ears before your wallet: a treatment table, the episodes behind it, and a listening order for the week you first notice thinning.
An old condition with a new sales machine
The biology is as old as ever: roughly half of men show noticeable androgenetic hair loss by fifty, and it often starts in the twenties. Three things changed around it. Telehealth turned treatment into e-commerce, with companies prescribing finasteride and minoxidil through an online questionnaire and spending heavily on podcast ads (the shows tracking that shift are in our roundup of podcasts on the telehealth boom). Men talk about hair loss openly now, which is good, and are marketed to relentlessly, which is mixed. Medical tourism exploded too: Istanbul became the world's best-known transplant destination, and before-and-after videos became their own social media genre. Finally, a few huge podcast episodes turned hair loss into an optimization topic. The result is more men treating earlier, which helps, because keeping follicles is easier than reviving them.
The treatments, side by side
| Treatment | What the evidence says | Main caution | Episode that covers it |
|---|---|---|---|
| Finasteride, oral 1 mg | The best-studied option for men: in five-year label data, 90% on it kept or regrew hair, against 25% on placebo. | Sexual side effects in a small minority (see below); EU labels added suicidal thoughts in 2025. Pregnant women must avoid contact. | Huberman Lab; More Plates More Dates |
| Minoxidil, topical | Over-the-counter for decades; modest regrowth and slower loss while used. | Irritation and early shedding; gains fade after stopping. | Huberman Lab |
| Minoxidil, low-dose oral | Off-label, with a growing body of studies and wide dermatology use. | Extra body hair in about one in seven users; less often fluid retention or a faster heart rate. Needs a prescriber. | Dermasphere; Huberman Lab |
| Dutasteride | Stronger DHT suppression; approved for hair loss in South Korea and Japan, off-label elsewhere. | Similar sexual side effects, a long half-life, and an EU mood-change warning. | More Plates More Dates |
| Finasteride, topical | Approved as a spray in parts of Europe. | US versions are compounded only; the FDA warned about them in April 2025. | More Plates More Dates |
| Microneedling | Small trials show extra regrowth when combined with minoxidil. | An add-on; technique and hygiene matter. | Huberman Lab |
| Hair transplant | Works for the right candidate. | Surgery costing thousands; only sensible once medication has stabilized the loss. | Clinic interviews on Skin Anarchy |
| Ketoconazole shampoo, supplements | A small boost from the shampoo; supplements help mainly in documented deficiency (iron, vitamin D), and saw palmetto acts as finasteride's much weaker cousin. | Most of the supplement aisle is hope in capsule form. | Huberman Lab |
The Huberman deep dive
Huberman Lab's April 2023 episode, "The Science of Healthy Hair, Hair Loss and How to Regrow Hair", is the most useful mainstream episode on the subject. Andrew Huberman covers the hair cycle (anagen, catagen, telogen, and why shed hairs are a poor measure of loss) and what dihydrotestosterone does to susceptible follicles, then works down most of the table above. Its core message: the earlier you act, the more you keep. If you hear one hour on this topic, make it this one.
What dermatologists tell each other
On Dermasphere, academic dermatologists Michelle Tarbox and Luke Johnson review new research for other clinicians. Hair comes up as studies publish: androgenetic alopecia data, the JAK-inhibitor drugs that changed treatment of alopecia areata (the autoimmune form), and the shift toward low-dose oral minoxidil, a decades-old blood pressure drug whose off-label revival at tiny doses has changed clinical practice. It's technical, and it is the best filter against marketing you'll find. Skin Anarchy (formerly Skincare Anarchy), hosted by Dr. Ekta Yadav, interviews founders, hair brands and clinic chains: useful for the business machinery, with the caveat that founder interviews are friendly territory by design.
Where the finasteride argument happens
More Plates More Dates is where the finasteride debate actually plays out. Its host Derek built a large audience on hormone pharmacology and co-founded Marek Health. He covers DHT, 5-alpha-reductase inhibitors, the post-finasteride syndrome debate, topical finasteride and dutasteride in more depth than any medical show. The tone is bodybuilding internet; the pharmacology is solid. Because he engages the scary anecdotes and then gives base rates, the drugs end up sounding less frightening. Huberman has also covered finasteride and dutasteride with Dr. Kyle Gillett, a physician board-certified in family and obesity medicine, and our guide to the testosterone and TRT debate on podcasts covers the wider hormone picture.
Reading the side-effect numbers
In the pooled trials behind the US label, 3.8% of men on finasteride 1 mg reported a sexual side effect in the first year, compared with 2.1% on placebo, and each effect fell to 0.3% or less by year five. Expectation matters: in a small Italian trial of the 5 mg prostate dose, men warned about sexual side effects reported them far more often than men who weren't (43.6% against 15.3%). Regulators still take reported harms seriously. In May 2025 the European Medicines Agency's safety committee confirmed suicidal ideation as a side effect of oral finasteride, at a frequency it could not estimate. The medical shows lean on trial data and the nocebo effect; the community shows take individual reports seriously and discuss exit ramps. Hearing each side prepares you for a proper conversation with a doctor about a drug you may take for decades.
How online hair loss prescription services work
Many of the hair loss ads on men's health podcasts come from online prescription services. The model is similar across most of them. You fill in a medical questionnaire, often upload photos of your scalp, and a licensed clinician reviews it, frequently without a live call. If approved, the medication ships on a subscription. The differences sit in the details. Some services sell the same generic finasteride and minoxidil any pharmacy stocks. Others push their own compounded blends, such as topical finasteride mixed with minoxidil, which in the US carry no FDA approval as finished products. Before paying, check who the prescriber is and whether you can message them later, whether each drug is a regulated product or a compound, how cancelling works, and whether you can fill the prescription at a pharmacy of your choice. The More Plates More Dates episodes on topical finasteride give useful background on the compounding question.
If you've just noticed thinning
Start this week with the Huberman hair episode for the biology and the full menu. Next, play a More Plates More Dates finasteride episode, so you hear the side-effect debate with numbers before the internet scares you. Then sample Dermasphere's segments on oral minoxidil to hear how dermatologists discuss the same drugs. After that, book an appointment, in person or with a licensed telehealth service prescribing regulated medication, and bring your questions. Nearly every credible source lands on the generic drugs in the top rows of the table, and every expert agrees on starting early.
Episodes referenced come from shows tracked in Reason.fm's Health & Fitness and Medicine charts.
This article looks at how podcasts discuss the topic and is not medical advice. Talk to a doctor or other qualified clinician about your own situation before starting, changing or stopping any treatment.